BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15378281)

  • 1. NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.
    Cao MY; Lee Y; Feng N; Li H; Du C; Miao D; Li J; Lee V; Jin H; Wang M; Gu X; Wright JA; Young AH
    Cancer Immunol Immunother; 2005 Mar; 54(3):229-42. PubMed ID: 15378281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.
    Li H; Cao MY; Lee Y; Lee V; Feng N; Benatar T; Jin H; Wang M; Der S; Wright JA; Young AH
    Cancer Immunol Immunother; 2005 Nov; 54(11):1115-26. PubMed ID: 15891881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.
    Benatar T; Cao MY; Lee Y; Li H; Feng N; Gu X; Lee V; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
    Cancer Immunol Immunother; 2008 Dec; 57(12):1757-69. PubMed ID: 18351336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.
    Li H; Cao MY; Lee Y; Benatar T; Lee V; Feng N; Gu X; Liu P; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
    Int Immunopharmacol; 2007 Oct; 7(10):1350-9. PubMed ID: 17673150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages play a critical role in the anti-tumor activity of Virulizin.
    Du C; Feng N; Jin H; Lee V; Wang M; Wright JA; Young AH
    Int J Oncol; 2003 Nov; 23(5):1341-6. PubMed ID: 14532975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical efficacy of Virulizin in human breast, ovarian and prostate tumor models.
    Du C; Feng N; Jin H; Wang M; Wright JA; Young AH
    Anticancer Drugs; 2003 Apr; 14(4):289-94. PubMed ID: 12679733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virulizin-2gamma, a novel immunotherapeutic agent, in treatment of human pancreatic cancer xenografts.
    Liu C; Ferdinandi ES; Ely G; Joshi SS
    Int J Oncol; 2000 May; 16(5):1015-20. PubMed ID: 10762639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of Virulizin, a novel biological response modifier (BRM) in a panel of human pancreatic cancer and melanoma xenografts.
    Feng N; Jin H; Wang M; Du C; Wright JA; Young AH
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):247-55. PubMed ID: 12655444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natural killer cells in adenovirus-mediated p53 gene therapy.
    Carroll JL; Nielsen LL; Pruett SB; Mathis JM
    Mol Cancer Ther; 2001 Nov; 1(1):49-60. PubMed ID: 12467238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo CD40 ligation can induce T-cell-independent antitumor effects that involve macrophages.
    Lum HD; Buhtoiarov IN; Schmidt BE; Berke G; Paulnock DM; Sondel PM; Rakhmilevich AL
    J Leukoc Biol; 2006 Jun; 79(6):1181-92. PubMed ID: 16565324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis-associated macrophages constrain antitumor capability of natural killer cells in the metastatic site at least partially by membrane bound transforming growth factor β.
    Brownlie D; Doughty-Shenton D; Yh Soong D; Nixon C; O Carragher N; M Carlin L; Kitamura T
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33472858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody.
    Hiramatsu K; Serada S; Kobiyama K; Nakagawa S; Morimoto A; Matsuzaki S; Ueda Y; Fujimoto M; Yoshino K; Ishii KJ; Enomoto T; Kimura T; Naka T
    Cancer Sci; 2015 Oct; 106(10):1474-8. PubMed ID: 26498112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
    Yang H; Dithmar S; Grossniklaus HE
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement.
    Di Carlo E; Comes A; Basso S; De Ambrosis A; Meazza R; Musiani P; Moelling K; Albini A; Ferrini S
    J Immunol; 2000 Sep; 165(6):3111-8. PubMed ID: 10975824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
    Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
    J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases.
    Dhupkar P; Gordon N; Stewart J; Kleinerman ES
    Cancer Med; 2018 Jun; 7(6):2654-2664. PubMed ID: 29733528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice.
    Hardy B; Kovjazin R; Raiter A; Ganor N; Novogrodsky A
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5756-60. PubMed ID: 9159146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
    Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
    Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation.
    Elinav E; Abd-Elnabi A; Pappo O; Bernstein I; Klein A; Engelhardt D; Rabbani E; Ilan Y
    J Hepatol; 2006 Mar; 44(3):529-36. PubMed ID: 16310278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.